137 – Investigating the Science Behind Doping Motivations and Psychosocial Predictors of Doping – Nikos Ntoumanis, PhD
Dr. Nikos Ntoumanis is Professor and Director in the Danish Centre for Motivation and Behaviour Science in the Department of Sports Science and Clinical Biomechanics at the University of Southern Denmark. In this episode, Nikos discusses important research he has been conducting on factors that are relevant for doping intentions and doping behaviors, including environmental factors like the style of coaching an athlete receives, as well as athletes’ personal motivations and moral attitudes. He also discusses a recent a PCC-funded meta-analysis that provides an updated look at the evidence on personal and psychosocial predictors of doping use in physical activity settings.
Support This Podcast
Interested in sponsoring the Anti-Doping Podcast or have a guest recommendation?
64 – Developing Novel Anti-Doping Assays to Monitor Collagen Turnover – Andy Hoofnagle, MD, PhD
Dr. Andy Hoofnagle is a researcher, professor, board certified pathologist, and laboratory director at the University of Washington. Dr. Hoofnagle’s laboratory focuses on research and development of novel biomarker assays that use mass spectrometry. Andy joins us in this episode to discuss his work in anti-doping, specifically with a focus on the development of assays to measure markers of collagen turnover for anti-doping applications.
63 – How to Secure Anti-Doping Research Funding – Annette Salmeen, PhD
Dr. Annette Salmeen was a 1996 Olympian and gold medalist in swimming. In 2005, she was elected as an athlete member of the USADA Board of Directors, and she served on the board until 2012. Currently, Annette is a lecturer and Core Course Coordinator in the Human Biology Program at Stanford University, and she’s also a member of the Partnership for Clean Competition’s Scientific Advisory Board. In this episode she discusses best practices for applying for anti-doping research grants from the PCC.
62 – The Anti-Doping Agency of Kenya’s Commitment to Clean Sport – Sarah Shibutse
Sarah Shibutse is the Director of Standards and Compliance at the Anti-Doping Agency of Kenya (ADAK). She served as a joint secretary to the Anti-Doping Task Force that was set up by the Ministry of Sports to investigate the extent of doping in Kenya. In this episode, we discuss the findings of this Task Force and the history of ADAK. Sarah shares what it was like creating a national anti-doping organization from the ground up, current challenges they are facing, their goals for the future, and more.
61 – Delivering Innovative Solutions to Fight Doping and Other Sport Integrity Issues – Dominic Mueser
Dominic Mueser has worked in anti-doping for more than a decade, much of it with Germany’s national anti-doping agency. Today, he works at Sportradar, where he serves as the Global Head of Anti-Doping Services. Sportradar primarily collects and analyzes sports data, providing information to everyone from international sports federations to bookmakers. Dominic joins us in this episode to discuss Sportradar’s role in the anti-doping space and how data can be used to help ensure clean sport.
60 – Leading Rigorous Anti-Doping Efforts in Canada – Jeremy Luke
Jeremy Luke is Senior Director of Sport Integrity at the Canadian Center for Ethics in Sport (CCES), the Canadian national anti-doping organization (NADO). He also led the anti-doping program for the Vancouver Olympic and Paralympic Games in 2010. Jeremy joins us in this episode to talk about CCES, discuss how NADO’s have been dealing with the pandemic, and share his insights into what it takes to run anti-doping efforts during the Olympic and Paralympic Games.
59 – Developing New Activity-Based Bioassays to Screen for HIF Stabilizers – Liesl Janssens
Liesl Janssens is a PhD student in the Lab of Toxicology at Ghent University. Her virtual poster was a finalist in the PCC’s 2021 virtual poster session in the category of Pilot Studies. She is developing novel activity-based bioassays to screen for performance enhancing hypoxia-inducible factor (HIF) stabilizers. HIF stabilizers are small molecules that help to produce more blood cells by stimulating endogenous erythropoietin production. She shares more about this project and her work in this episode.
58 – Cycling Benefits from New Partnership with the International Testing Agency – Olivier Banuls
Olivier Banuls served as the director for the Cycling Anti-Doping Foundation (CADF), and he is now working with the International Testing Agency (ITA) to help fight doping in cycling. He joins us in this interview to talk about the ITA and their new anti-doping efforts in the sport of cycling in collaboration with the Union Cycliste Internationale (UCI). This is the second of our two-episode mini-series taking an in-depth look at anti-doping in cycling, in conjunction with the Tour de France this month.
57 – UCI’s Dedication to Advancing Clean Sport in Cycling – Amina Lanaya
Amina Lanaya is the Director General for the Union Cycliste Internationale (UCI). She joins us in this episode to discuss UCI’s history, current anti-doping issues in cycling, UCI’s recent partnership with the International Testing Agency (ITA) to help combat doping in cycling, and more. This is the first episode of our two-part mini-series focused on anti-doping in cycling in conjunction with the ongoing Tour de France.
56 – JADA’s Role in the Tokyo 2020 Games and Legacy Projects – YaYa Yamamoto, PhD
Dr. YaYa Yamamoto is the Senior Manager of Education & International Relations at the Japan Anti-Doping Agency (JADA). JADA has been critical in helping prepare for the Tokyo Olympic and Paralympic Games, and Dr. Yamamoto has been leading JADA’s initiatives to deliver sporting values-based and anti-doping programs. She is also a member of WADA’s education committee and the International Testing Agency (ITA) International Expert Group. We discuss JADA, the upcoming Games, and more in this episode.
55 – Improving Anti-Doping and Integrity in Biathlon – Greg McKenna
Greg McKenna brings a rich background in investigation and law enforcement to his current position as Head of Biathlon Integrity Unit. In this episode, Greg discusses biathlon, doping concerns for biathletes, recent changes in the sport, development of the Biathlon Integrity Unit, and how he is applying his unique experiences to help continue to develop and refine anti-doping and integrity efforts in biathlon.
54 – An In-Depth Look at Anti-Doping Law and Arbitration – Janie Soublière
Janie Soublière is a sports lawyer and arbitrator. She’s done arbitration and legal work for everyone from the International Court of Arbitration for Sport (CAS) to the Ultimate Fighting Championship’s Anti-Doping Panel. In this episode, Janie discusses her wide array of experiences working on anti-doping cases, tribunals, and arbitration panels. She walks us through the arbitration process for anti-doping cases and shares her insights on some of the next big challenges for anti-doping law.
53 – Enhancing Anti-Doping and Safety in Horseracing – Jim Gagliano
Jim Gagliano is the President and Chief Operating Officer of The Jockey Club, the breed registry for all thoroughbred horses in North America. He also sits on a number of councils and boards related to horse racing. In this episode, we discuss horse racing’s approach to anti-doping, current anti-doping and safety priorities, and recent changes over the past year as a result of some high-profile cases and new legislation.
52 – Developing Molecularly Imprinted Polymers for Anti-Doping – Rachel Hand, PhD
Dr. Rachel Hand is a Research Fellow in Polymer Chemistry at The University of Warwick. In this episode, Dr. Hand discusses her work in the area of advancements in molecularly imprinted polymers and their role in anti-doping as well as her experiences working with the PCC on a recent research project. Plus, we talk about social media and its role in facilitating scientific collaboration in clean sport.
51 – Anti-Doping Efforts and Recent Changes in Weightlifting – Phil Andrews
Phil Andrews is the Chief Executive Officer of USA Weightlifting. He has brought about significant reform to weightlifting internationally, especially in the area of anti-doping. In this episode, he discusses USA Weightlifting’s anti-doping efforts, recent controversy with the International Weightlifting Federation, implications for participation in the Olympic and Paralympic Games, and the way forward for the sport to ensure clean competition.
50 – Advocating for Athletes in Sport and Anti-Doping Law – Howard Jacobs, JD
Howard Jacobs is an attorney and a leading advocate for athletes around the world in doping matters. He has represented more than 300 athletes in disciplinary cases related to various issues in sport. In this interview, Howard shares insights about what it’s like working in anti-doping law, walks through the steps he takes when working on an anti-doping case, and discusses experiences from some of the most memorable and prominent cases he has been involved in over the years.
49 – Developing Novel Methods to Detect Blood Doping – Jean-Francois Naud, PhD
Dr. Jean-Francois Naud is Deputy Director and Research Associate at the Doping Control Laboratory of the National Institute of Scientific Research (INRS) in Québec, Canada. In our interview, he discusses his work at the WADA-accredited Doping Control Laboratory, his path to becoming an anti-doping scientist, his research to improve our ability to detect blood doping, his role in anti-doping testing during the 2010 Olympic Games in Vancouver, and current challenges in anti-doping research.
48 – Detecting Doping with Steroids Using the Athlete Biological Passport – Federico Ponzetto, PhD
Dr. Federico Ponzetto is a part of the PCC Fellowship Program and a Postdoctoral Research Fellow in the Department of Medical Sciences of the University of Turin in Italy. In this interview, we discuss the Steroid Module of the Athlete Biological Passport (ABP) and how Dr. Ponzetto’s research will impact the ABP. He also shares his experiences as a PCC Fellow, complete with advice for those who might be considering this path for themselves or a colleague.
47 – Updates on Research at the World Anti-Doping Agency – Marcia MacDonald, PhD
Dr. Marcia MacDonald is a Deputy Director of Science and Medicine at the World Anti-Doping Agency (WADA). In this interview, we discuss how Marcia began her career in anti-doping, the history of WADA’s anti-doping research program, and their current research priorities. She also shares information about new and ongoing anti-doping research projects, funding opportunities for researchers, implementation of newly developed anti-doping techniques and technology, and more.
46 – International Sports Law, Arbitration, and Anti-Doping – Dr. Despina Mavromati
Dr. Despina Mavromati is an attorney with SportLegis Lausanne specializing in international sports law and arbitration. She is also a Member of the Appeals Body of The Union of European Football Associations, a Member of the Independent Disciplinary Tribunal of World Athletics, and a Member of the Faculty of Law, Criminal Justice and Public Administration of the University of Lausanne. In this episode, we talk about current issues in anti-doping law and arbitration, Despina’s career, and her work.
45 – Applications of Tandem Mass Spec, Bioinformatics, and Proteomics in Anti-Doping – John Yates III, PhD
Dr. John Yates is the Ernest W. Hahn Professor in the Departments of Molecular Medicine and Neurobiology at The Scripps Research Institute in California. He is also a member of the PCC’s Scientific Advisory Board and a world-renowned expert in proteomics. In this episode, he discusses his career path, his research, impacts of the global pandemic, and potential applications of advanced analytical approaches such as tandem mass spec, bioinformatics, and proteomics for anti-doping.
44 – An In-Depth Look at Anti-Doping Investigations at Major League Baseball – Moira Weinberg, JD
Moira Weinberg is Vice President of Investigations and Deputy General Counsel at Major League Baseball (MLB). In our interview, she discusses the formation and organization of Major League Baseball’s Department of Investigations, some of the different types of cases they handle, the general process involved in conducting investigations for anti-doping and other cases, key anti-doping programs and resources for players, and some of the major challenges and priorities for MLB investigations.
43 – Remote Drug Testing and Preparing For Future Crises – Matthew Fedoruk, PhD
Dr. Matthew Fedoruk is Chief Science Officer at the United States Anti-Doping Agency (USADA). In this interview, we talk about USADA’s new remote drug testing program, how USADA has been impacted by the COVID-19 pandemic, major challenges the global anti-doping community is currently facing, and his role in the World Anti-Doping Agency (WADA)’s Strategic Testing Expert Group focused on preparing for future crises.
42 – Paralympic Powerlifter Advocates for Anti-Doping – Ali Jawad
Ali Jawad is an accomplished British powerlifter and Board Member of the Commonwealth Games Team England. He was awarded a bronze medal in the 2018 Commonwealth Games, a silver medal in the 2016 Paralympic Games, and gold medals in the 2015 IPC Powerlifting European Championships and 2014 IPC Powerlifting World Championships. Ali discusses his career, some of the challenges he has faced, his perspective on anti-doping as an elite athlete, and his work as a Member of the Start Up Group with Global Athlete.
41 – The Impacts of COVID-19 on the Olympic and Paralympic Games – Jonathan Finnoff, DO
Dr. Jonathan Finnoff is Chief Medical Officer of the U.S. Olympic and Paralympic Committee (USOPC). In our interview, he discusses the timeline of events leading up to the postponement of the 2020 Olympic and Paralympic Games, the broad spectrum of effects this pandemic has had on athletes, new protocols and safety measures in place at training centers, anti-doping and COVID-19 testing procedures, and how the USOPC has been dealing with some of the major challenges that have arisen during this pandemic.
40 – How PGA TOUR Is Handling COVID-19 – Andy Levinson
Andy Levinson is Senior Vice President of Tournament Administration at PGA TOUR and Executive Director of USA GOLF. In our interview, he provides an insider look at how PGA TOUR has navigated some of the major challenges posed by the COVID-19 pandemic and the new protocols and restrictions they have put in place to protect players, staff, and spectators. He also discusses their innovative solution to addressing issues surrounding COVID-19 testing for players, impacts on their anti-doping programs, and more.